Search research articles
Contact Us
Filters
Showing results (151-160 of 280) with videos related to
Page
of 28
Sort By:
JCO Clinical Cancer Informatics
|
July 16, 2025
Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial
Russ A Kuker, Juan P Alderuccio, Sunwoo Han, et al.
European Journal of Biochemistry
|
June 1, 1997
Anti-insect toxin 5 (AaIT5) from Androctonus australis
Y Nakagawa, Y M Lee, E Lehmberg, et al.
British Journal of Haematology
|
June 9, 2006
Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma
Tarun Kewalramani, Andrew D Zelenetz, Julie Teruya-Feldstein, et al.
The Journal of Antimicrobial Chemotherapy
|
March 1, 1994
The activity of 2-substituted quinoline alkaloids in BALB/c mice infected with Leishmania donovani
A Fournet, J C Gantier, A Gautheret, et al.
Cancers
|
November 11, 2022
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma
Russ A Kuker, David Lehmkuhl, Deukwoo Kwon, et al.
Leukemia & Lymphoma
|
April 22, 2014
Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide
Mary R Welch, Craig S Sauter, Matthew J Matasar, et al.
Blood Advances
|
June 20, 2020
KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure
Philippe Armand, John Kuruvilla, Jean-Marie Michot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma
A K Gopal, M A Fanale, C H Moskowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 19, 2014
Pretransplantation fluorine-18-deoxyglucose--positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation
Craig S Sauter, Lauren Lechner, Michael Scordo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 24, 2017
Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience
Andreas Rimner, Shona Lovie, Meier Hsu, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 280) with videos related to
Sort By:
Page
of 28
JCO Clinical Cancer Informatics
|
July 16, 2025
Deep Learning-Based Body Composition Analysis for Outcome Prediction in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Insights From the LOTIS-2 Trial
Russ A Kuker, Juan P Alderuccio, Sunwoo Han, et al.
European Journal of Biochemistry
|
June 1, 1997
Anti-insect toxin 5 (AaIT5) from Androctonus australis
Y Nakagawa, Y M Lee, E Lehmberg, et al.
British Journal of Haematology
|
June 9, 2006
Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma
Tarun Kewalramani, Andrew D Zelenetz, Julie Teruya-Feldstein, et al.
The Journal of Antimicrobial Chemotherapy
|
March 1, 1994
The activity of 2-substituted quinoline alkaloids in BALB/c mice infected with Leishmania donovani
A Fournet, J C Gantier, A Gautheret, et al.
Cancers
|
November 11, 2022
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma
Russ A Kuker, David Lehmkuhl, Deukwoo Kwon, et al.
Leukemia & Lymphoma
|
April 22, 2014
Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide
Mary R Welch, Craig S Sauter, Matthew J Matasar, et al.
Blood Advances
|
June 20, 2020
KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure
Philippe Armand, John Kuruvilla, Jean-Marie Michot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma
A K Gopal, M A Fanale, C H Moskowitz, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 19, 2014
Pretransplantation fluorine-18-deoxyglucose--positron emission tomography scan lacks prognostic value in chemosensitive B cell non-hodgkin lymphoma patients undergoing nonmyeloablative allogeneic stem cell transplantation
Craig S Sauter, Lauren Lechner, Michael Scordo, et al.
International Journal of Radiation Oncology, Biology, Physics
|
March 24, 2017
Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience
Andreas Rimner, Shona Lovie, Meier Hsu, et al.
Page
of 28